SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(McIlleron Helen M.)
 

Sökning: WFRF:(McIlleron Helen M.) > Pharmacokinetics of...

Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection : a systematic review

Jacobs, Tom G. (författare)
Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Pharm, Nijmegen, Netherlands.
Svensson, Elin, 1985- (författare)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Pharm, Nijmegen, Netherlands,Farmakometri
Musiime, Victor (författare)
Joint Clin Res Ctr, Res Dept, Kampala, Uganda.;Makerere Univ, Coll Hlth Sci, Sch Med, Dept Paediat & Child Hlth, Kampala, Uganda.
visa fler...
Rojo, Pablo (författare)
Univ Complutense, Hosp 12 Octubre, Fac Med, Pediat Infect Dis Unit, Madrid, Spain.
Dooley, Kelly E. (författare)
Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA.;Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.
McIlleron, Helen (författare)
Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa.
Aarnoutse, Rob E. (författare)
Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Pharm, Nijmegen, Netherlands.
Burger, David M. (författare)
Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Pharm, Nijmegen, Netherlands.
Turkova, Anna (författare)
UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit UCL, London, England.
Colbers, Angela (författare)
Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Pharm, Nijmegen, Netherlands.
visa färre...
Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Dept Pharm, Nijmegen, Netherlands Institutionen för farmaceutisk biovetenskap (creator_code:org_t)
2020-08-12
2020
Engelska.
Ingår i: Journal of Antimicrobial Chemotherapy. - : Oxford University Press (OUP). - 0305-7453 .- 1460-2091. ; 75:12, s. 3433-3457
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • Introduction: Management of concomitant use of ART and TB drugs is difficult because of the many drug-drug interactions (DDIs) between the medications. This systematic review provides an overview of the current state of knowledge about the pharmacokinetics (PK) of ART and TB treatment in children with HIV/TB co-infection, and identifies knowledge gaps. Methods: We searched Embase and PubMed, and systematically searched abstract books of relevant conferences, following PRISMA guidelines. Studies not reporting PK parameters, investigating medicines that are not available any Longer or not including children with HIV/TB co-infection were excluded. ALL studies were assessed for quality. Results: In total, 47 studies met the inclusion criteria. No dose adjustments are necessary for efavirenz during concomitant first-Line TB treatment use, but intersubject PK variability was high, especially in children <3 years of age. Super-boosted Lopinavir/ritonavir (ratio 1:1) resulted in adequate Lopinavir trough concentrations during rifampicin co-administration. Double-dosed raltegravir can be given with rifampicin in children >4 weeks old as well as twice-daily dolutegravir (instead of once daily) in children older than 6 years. Exposure to some TB drugs (ethambutol and rifampicin) was reduced in the setting of HIV infection, regardless of ART use. Only Limited PK data of second-Line TB drugs with ART in children who are HIV infected have been published. Conclusions: Whereas integrase inhibitors seem favourable in older children, there are Limited options for ART in young children (<3 years) receiving rifampicin-based TB therapy. The PK of TB drugs in HIV-infected children warrants further research.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
for (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy